Vertex Pharmaceuticals Down 4.3% Since SmarTrend's Sell Recommendation
Oct 29, 2009 (SmarTrend(R) Spotlight via COMTEX) --
Company: Vertex Pharmaceuticals Inc. (VRTX)
SmarTrend, our proprietary pattern recognition system, called a Downtrend for Vertex Pharmaceuticals (NASDAQ:VRTX) on October 05, 2009 at $34.57.
Since then, Vertex Pharmaceuticals has returned 4.3% as of today's recent price of $33.10. Want to profit from these alerts?
Go to www.mysmartrend.com now for a FREE two-week trial.
Write to Chip Brian at cbrian@tradethetrend.com
---------------------------------------------------------------------------------------------
SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit http://www.TradeTheTrend.com.
Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at: http://www.TradeTheTrend.com/signup.html
Copyright (C) 2009 Comtex SmarTrend(R). All rights reserved
News Provided by COMTEX
Company: Vertex Pharmaceuticals Inc. (VRTX)
Related terms: market, nasdaq, pharmaceuticals, profit, securities, trial
